DNA: Ginkgo Bioworks Corp. Amount of Cash per Share

An analysis of cash per share for Ginkgo Bioworks Holdings (DNA) demonstrates how the company implements ESG principles through synthetic biology to replace industrial chemistry. The transition of laboratories to renewable energy sources and plastic biosynthesis strengthens the environmental profile. The value of 4.43 expresses the metric level, while scalable cell "code" for medicine and food products provides potential for high margins.
Comprehensive metric breakdowns and analytics for Ginkgo Bioworks Holdings, Inc. (DNA)

Ginkgo Bioworks Holdings (DNA) investments in AI developers and laboratory automation are directly reflected in the free liquidity per share trend, demonstrating the company's ability to fund headcount expansion. This metric is calculated as the ratio of net cash balance to the number of shares, allowing investors to assess the business's real cash foundation excluding accounting adjustments and determine the company's margin of safety.